Free shipping on all orders over €250
Wunschliste (0)
  • Warenkorb ist noch leer.


  • Hersteller British Dragon
  • Artikelnr. Nandrolone Phenylpropionate
  • Verfügbarkeit 150

Durabol Inject

General information:

CAS Name: 3-Oxoestr-4-en-17beta-yl 3-phenylpropionate

Nandrolone phenylpropionate is an injectable anabolic androgenic steroid. It is attached to a short ester. It is indicated for the management of the anemia of renal insufficiency and has been shown to increase hemoglobin and red cell mass. Nandrolone cannot be reduced by 5-alpha reductase into DHT and therefore does not have an adverse reaction on the prostate. Instead of DHT, nandrolone metabolizes into dihydronandrolone.

Nandrololones does not convert into estrogens. Nandrolone binds well to androgen receptors and also possesses non-receptor mediated stimulation on muscle growth. Nandrolone phenylpropionate is one of the most potent anabolic steroid for muscle growth with an excellent myotrophic activity index of 3.29–4.92. Nandrolone up-regulates androgen receptor AR expression in skeletal muscle, thus potentiating the actions of other steroids. Nandrolone does not have alkylation on the 17α-carbon and therefore is not toxic to the liver.

each mL contains:

Nandrolone Phenylpropionate


100 mg

Benzyl Alcohol


3.0% v/v

Ethyl Oleate



Packing: 10 mL Glass Vial

Additional information:

  • Dosage and administration

    Adult dose is 25-50mg by intramuscular injection per week.

    Active life: 2-3 days.

  • Contraindications

    Male patients with carcinoma of the breast or with known or suspected carcinoma of the prostate.

    Carcinoma of the breast in females with hypercalcemia: androgenic anabolic steroids may stimulate osteolytic resorption of bones. Pregnancy, because of masculinization of the fetus. Nephrosis or the nephrotic phase of nephritis.

  • Adverse reactions

    Genitourinary System:

    In men:

    a) Prepubertal: Phallic enlargement and increased frequency of erections. b) Postpubertal: Inhibition of testicular function, testicular atrophy and oligospermia, impotence, chronic priapism, epididymitis and bladder irritability.

    In women: Clitoral enlargement, menstrual irregularities.

    In both sexes: Increased or decreased libido.

  • Drug/Laboratory test interactions

    Therapy with nandrolone decanoate may decrease thyroxine-binding globulin resulting in decreased total T4 serum levels and increased resin uptake of T3 and T4. Free thyroid hormone levels remain unchanged. Increased creatine and creatinine excretion, increased serum levels of creatinine phosphokinase (CPK).

Neue Beurteilung

Bitte anmelden oder registrieren um Beurteilung zu schreiben